Abstract
The Fatigue Impact Scale for Daily Use (D-FIS) was used in a cross-sectional study including 142 consecutive Parkinson’s disease (PD) patients. Usual clinical measures for PD, the Montgomery-Asberg Depression Rating Scale and the Parkinson’s Disease Questionnaire-8 items were applied. In addition to the D-FIS, patients with fatigue (67.6%, PWF) completed the Multidimensional Fatigue Inventory (MFI), a visual analogue scale for fatigue (VAS-F) and a Global Perception of Fatigue scale (GPF). Relevant psychometric D-FIS results were: floor effect = 4.2%; ceiling effect = 1.1%; skewness = 0.44; item homogeneity = 0.63; Cronbach’s α = 0.93; item-total correlation = 0.68 (item 1)−0.82 (item 8); standard error of measurement = 2.15; convergent validity with other fatigue measures = 0.54 [GPF]−0.62 [VAS-F] (p<0.001). In a multiple linear regression model, fatigue, depression, and disability independently influenced HRQoL, as measured by the PDQ-8. Patients on amantadine had lower prevalence of fatigue. In PD, D-FIS is a consistent and valid measure for fatigue, a frequent symptom previously found to impair patients’ HRQoL. Fatigue was also linked to depression and disability in this study.
Similar content being viewed by others
Abbreviations
- FIS:
-
Fatigue Impact Scale
- D-FIS:
-
Fatigue Impact Scale for daily use
- GPF:
-
Global Perception of Fatigue scale
- HRQoL:
-
Health-related quality of life
- HY:
-
Hoehn and Yahr Classification
- ISAPD:
-
Intermediate Scale for Assessment of Parkinson’s Disease
- IR:
-
Interquartile rank
- MADRS:
-
Montgomery-AsbergDepression Rating Scale
- MFI:
-
Multidimensional Fatigue Inventory
- MFI-GF:
-
Multidimensional Fatigue Inventory-General Fatigue
- PD:
-
Parkinson’s disease
- PDQ-8:
-
Parkinson’s Disease Questionnaire-8 Items
- PDQ-8 SI:
-
Parkinson’s Disease Questionnaire-8 Items Summary Index
- PWF:
-
Patients with fatigue
- PNF:
-
Patients without fatigue
- SES:
-
Schwab and England Scale
- UPDRS:
-
Unified Parkinson’s Disease Rating Scale
- VAS-F:
-
Visual analogue scale for fatigue
References
S Wessely M Sharpe (1995) Chronic fatigue syndrome, and fibromyalgia R Mayou C Bass M Sharpe (Eds) Treatment of Functional Somatic Symptoms Oxford Univ Press New York 285–312
Nickols JR. Chronic fatigue syndrome. In: Gilman S (ed), Medlink Neurology. San Diego: Medlink Corporation. Available at http://www.medlink.com. Accessed April 6, 2005.
M Sharpe D Wilks (2002) ArticleTitleFatigue Br Med J 325 480–483
A Chaudhuri PO Behan (2004) ArticleTitleFatigue in neurological disorders Lancet 363 978–988 Occurrence Handle10.1016/S0140-6736(04)15794-2 Occurrence Handle15043967
LB Krupp LA Alvarez NG LaRocca LC Scheimberg (1988) ArticleTitleFatigue in multiple sclerosis Arch Neurol 45 435–437 Occurrence Handle1:STN:280:DyaL1c7ot1yqtw%3D%3D Occurrence Handle3355400
JD Fisk A Pontefract PG Ritvo CJ Archibald TJ Murray (1994) ArticleTitleThe impact of fatigue on patients with multiple sclerosis Can J Neural Sci 21 9–14 Occurrence Handle1:STN:280:DyaK2c3js1Ghsw%3D%3D
BL Belza CJ Henke EH Yelin WV Epstein CL Gilliss (1993) ArticleTitleCorrelates of fatigue in older women with rheumatoid arthritis Nursing Res 42 93–99 Occurrence Handle1:STN:280:DyaK3s3gsFGjtw%3D%3D Occurrence Handle10.1097/00006199-199303000-00006
EMA Smets B Grassen B Bonke JCJM Haes ParticleDe (1995) ArticleTitleThe multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue J Psychosom Res 39 315–325 Occurrence Handle10.1016/0022-3999(94)00125-O Occurrence Handle1:STN:280:DyaK2MzmtlOgsQ%3D%3D Occurrence Handle7636775
T Chalder G Berelowitz T Pawlikowska L Watts S Wessely D Wright EP Wallace (1993) ArticleTitleDevelopment of a fatigue scale J Psychosom Res 37 147–153 Occurrence Handle10.1016/0022-3999(93)90081-P Occurrence Handle1:STN:280:DyaK3s3hslyqtg%3D%3D Occurrence Handle8463991
J Iriarte G Katsamakis P Castro ParticleDe (1999) ArticleTitleThe fatigue descriptive scale (FDS): A useful tool to evaluate fatigue in multiple sclerosis Mult Scler 5 10–16 Occurrence Handle10.1191/135245899701564263 Occurrence Handle1:STN:280:DyaK1M7psFygsw%3D%3D Occurrence Handle10096097
JD Fisk SE Doble (2002) ArticleTitleConstruction and validation of a fatigue impact scale for daily administration (D-FIS) Qual Life Res 11 263–272 Occurrence Handle10.1023/A:1015295106602 Occurrence Handle12074263
WRG Gibb AJ Lees (1988) ArticleTitleThe relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease J Neurol Neurosurg Psychiatry 51 745–752 Occurrence Handle1:STN:280:DyaL1czgtVSqsg%3D%3D Occurrence Handle2841426
MM Hoehn MD Yahr (1967) ArticleTitleParkinsonism: Onset, progression, and mortality Neurology 17 427–442 Occurrence Handle1:STN:280:DyaF2s7jvFSgsg%3D%3D Occurrence Handle6067254 Occurrence Handle10.1159/000137111
RS Schwab AC England (1969) Projection technique for evaluating surgery in Parkinson’s disease FJ Gillingham IML Donaldson (Eds) Third Symposium on Parkinson’s Disease E and S Livingstone Edinburgh 152–157
S Fahn RL Elton InstitutionalAuthorName. Members of the UPDRS Development Committee (1987) Unified Parkinson’s disease rating scale S Fahn CD Marsden DB Calne M Goldstein (Eds) Recent Developments in Parkinson’s Disease NumberInSeries2 MacMillan Healthcare Information Florham Park, NJ 153–164
P Martinez-Martin A Gil-Nagel L Morlan Gracia et al. (1995) ArticleTitleIntermediate scale for assessment of Parkinson’s disease. Characteristics and structure Parkinsonism Relat Disord 1 97–102 Occurrence Handle10.1016/1353-8020(95)00002-X Occurrence Handle18591008
SA Montgomery M Asberg (1979) ArticleTitleA new depression scale designed to be sensitive to change Br J Psychiatry 134 382–389 Occurrence Handle1:STN:280:DyaE1M7ovVCksg%3D%3D Occurrence Handle444788 Occurrence Handle10.1192/bjp.134.4.382
C Jenkinson R Fitzpatrick V Peto R Greenhall N Hyman (1997) ArticleTitleThe PDQ-8: Development and validation of a short-form Parkinson’s disease questionnaire Psychol Health 12 805–814
K Karlsen JP Larsen E Tandberg K Jørgensen (1999) ArticleTitleFatigue in patients with Parkinson’s disease Mov Disord 14 237–241 Occurrence Handle10.1002/1531-8257(199903)14:2<237::AID-MDS1006>3.0.CO;2-X Occurrence Handle1:STN:280:DyaK1M7ptVSgtA%3D%3D Occurrence Handle10091615
V Peto C Jenkinson R Fitzpatrick R Greenhall (1995) ArticleTitleThe development and validation of a short measure of functioning and well being for individuals with Parkinson’s disease Qual Life Res 4 241–248 Occurrence Handle10.1007/BF02260863 Occurrence Handle1:STN:280:DyaK2MzjvVWqug%3D%3D Occurrence Handle7613534
P Martinez-Martin (2002) Calidad de vida relacionada con la salud en la Enfermedad de Parkinson Medicina stm Editores SL Barcelona 19–23
JD Fisk PG Ritvo L Ross DA Haase TJ Marrie WF Schlech (1994) ArticleTitleMeasuring the functional impact of fatigue: Initial validation of the fatigue impact scale Clin Infect Dis 18 IssueIDSuppl 1 79–83
C McHorney A Tarlov (1995) ArticleTitleIndividual-patient monitoring in clinical practice: Are available health status surveys adequate? Qual Life Res 4 293–307 Occurrence Handle10.1007/BF01593882 Occurrence Handle1:STN:280:DyaK28%2FksFamsw%3D%3D Occurrence Handle7550178
WC Holmes B Bix JA Shea (1996) ArticleTitleSF-20 score and item distributions in a human immunodeficiency virus-seropositive sample Med Care 34 562–569 Occurrence Handle10.1097/00005650-199606000-00006 Occurrence Handle1:STN:280:DyaK283lvVemtA%3D%3D Occurrence Handle8656722
JE Ware B Gandek InstitutionalAuthorNameIQOLA Project Group (1998) ArticleTitleMethods for testing data quality, scaling assumptions, and reliability: The IQOLA project approach J Clin Epidemiol 51 945–952 Occurrence Handle10.1016/S0895-4356(98)00085-7 Occurrence Handle9817111
InstitutionalAuthorNameScientific Advisory Committee of the Medical Outcomes Trust (2002) ArticleTitleAssessing health status and quality-of-life instruments: Attributes and review criteria Qual Life Res 11 193–205 Occurrence Handle10.1023/A:1015291021312
GH Guyatt S Walter G Norman (1987) ArticleTitleMeasuring change over time: Assessing the usefulness of evaluative instruments J Chronic Dis 40 171–178 Occurrence Handle10.1016/0021-9681(87)90069-5 Occurrence Handle1:STN:280:DyaL2s7jvVWitw%3D%3D Occurrence Handle3818871
KW Wyrwich MA Nienaber WM Tierney FD Wolinsky (1999) ArticleTitleLinking clinical relevance and statistical significance in evaluating intraindividual changes in health-related quality of life Med Care 37 469–478 Occurrence Handle10.1097/00005650-199905000-00006 Occurrence Handle1:STN:280:DyaK1M3ms1Orsg%3D%3D Occurrence Handle10335749
InstitutionalAuthorNameScientific Advisory Committee of the Medical Outcomes Trust (2002) ArticleTitleAssessing health status and quality-of-life instruments: Attributes and review criteria Qual Life Res 11 193–205 Occurrence Handle10.1023/A:1015291021312
R Fitzpatrick C Davey MJ Buxton DR Jones (1998) ArticleTitleEvaluating patient-based outcome measures for use in clinical trials Health Technol Assessm 2 IssueID14 25–28
J Friedman H Friedman (1993) ArticleTitleFatigue in Parkinson’s disease Neurology 43 2016–2018 Occurrence Handle1:STN:280:DyaK2c%2FitVahuw%3D%3D Occurrence Handle8413960
InstitutionalAuthorNameStataCorp (2003) Stata Statistical Software: Release 8.0 Stata Corporation College Station, TX
DG Altman (1997) Practical Statistics for Medical Research Chapman and Hall/CRC Boca Raton 453–460
K Herlofson JP Larsen (2002) ArticleTitleMeasuring fatigue in patients with Parkinson’s disease – The fatigue severity scale Eur J Neurol 9 595–600 Occurrence Handle10.1046/j.1468-1331.2002.00444.x Occurrence Handle1:STN:280:DC%2BD38npt1Cqug%3D%3D Occurrence Handle12453074
JJ Hilten Particlevan M Weggeman EA Velde Particlevan der GA Kerkhof JG Dijk Particlevan RAC Roos (1993) ArticleTitleSleep, excessive daytime sleepiness and fatigue in Parkinson’s disease J Neural Transm [Park Dis Dement Sect] 5 235–244 Occurrence Handle10.1007/BF02257678
K Abe M Takanashi T Yanagihara (2000) ArticleTitleFatigue in patients with Parkinson’s disease Behav Neurol 12 103–106 Occurrence Handle11455047
J-S Lou G Kearns B Oken G Sexton J Nutt (2001) ArticleTitleExacerbated physical fatigue and mental fatigue in Parkinson’s disease Mov Disord 16 190–196 Occurrence Handle10.1002/mds.1042 Occurrence Handle1:STN:280:DC%2BD3MvotlKgtg%3D%3D Occurrence Handle11295769
K Herlofson JP Larsen (2003) ArticleTitleThe influence of fatigue on health-related quality of life in patients with Parkinson’s disease Acta Neurol Scand 107 1–6 Occurrence Handle10.1034/j.1600-0404.2003.02033.x Occurrence Handle1:STN:280:DC%2BD3s%2FjsFGntw%3D%3D Occurrence Handle12542506
A Zenzola G Masi M Mari ParticleDe G Defazio P Livrea P Lamberti (2003) ArticleTitleFatigue in Parkinson’s disease Neurol Sci 24 225–226 Occurrence Handle10.1007/s10072-003-0142-y Occurrence Handle1:STN:280:DC%2BD3srit1KltA%3D%3D Occurrence Handle14600828
JE Schwartz L Jandorf LB Krupp (1993) ArticleTitleThe measurement of fatigue: A new instrument J Psychosom Res 37 IssueID7 753–762 Occurrence Handle10.1016/0022-3999(93)90104-N Occurrence Handle1:STN:280:DyaK2c%2Fks1OhsA%3D%3D Occurrence Handle8229906
RG Brown A Dittner L Findley SC Wessely (2005) ArticleTitleThe Parkinson fatigue scale Parkinsonism Relat Disord 11 49–55 Occurrence Handle10.1016/j.parkreldis.2004.07.007 Occurrence Handle1:STN:280:DC%2BD2cnkt12qsA%3D%3D Occurrence Handle15619463
I Ziv M Avraham Y Michaelov et al. (1998) ArticleTitleEnhanced fatigue during motor performance in patients with Parkinson’s disease Neurology 51 1583–1586 Occurrence Handle1:STN:280:DyaK1M%2FntFWntQ%3D%3D Occurrence Handle9855505
R Scott R Gregory N Hines et al. (1998) ArticleTitleNeuropsychological, neurological and functional outcome following pallidotomy for Parkinson’s disease. A consecutive series of eight simultaneous bilateral and twelve unilateral procedures Brain 121 659–675 Occurrence Handle10.1093/brain/121.4.659 Occurrence Handle9577392
K Straits-Tröster JA Fields SB Wilkinson R Pahwa KE Lyons WC Koller (2000) ArticleTitleHealth-related quality of life in Parkinson’s disease after pallidotomy and deep brain stimulation Brain Cogn 42 399–416 Occurrence Handle10.1006/brcg.1999.1112 Occurrence Handle10753487
J-S Lou G Kearns T Benice B Oken G Sexton J Nutt (2003) ArticleTitleLevodopa improves physical fatigue in Parkinson’s disease: A double-blind, placebo controlled, crossover study Mov Disord 18 1108–1114 Occurrence Handle10.1002/mds.10505 Occurrence Handle14534913
JK Bland DG Altman (1997) ArticleTitleCronbach’s alpha Br Med J 314 572 Occurrence Handle1:STN:280:DyaK2s3gvVOktA%3D%3D
JC Nunnally IH Bernstein (1994) Psychometric Theory EditionNumber3 McGraw-Hill New York
CA McHorney JE Ware SuffixJr JFR Lu CD Sherbourne (1994) ArticleTitleThe MOS 36-item short-form health survey (SF-36): III. Tests of data quality, scaling assumptions and reliability across diverse patient groups Med Care 32 40–66 Occurrence Handle1:STN:280:DyaK2c7gsVeltQ%3D%3D Occurrence Handle8277801
C McHorney A Tarlov (1995) ArticleTitleIndividual-patient monitoring in clinical practice: Are available health status surveys adequate? Qual Life Res 4 293–307 Occurrence Handle10.1007/BF01593882 Occurrence Handle1:STN:280:DyaK28%2FksFamsw%3D%3D Occurrence Handle7550178
G Alves T Wentzel-Larsen JP Larsen (2004) ArticleTitleIs fatigue an independent and persistent symptom in patients with Parkinson’s disease? Neurology 63 1908–1911 Occurrence Handle1:STN:280:DC%2BD2crosFOlsg%3D%3D Occurrence Handle15557510
KH Karlsen E Tandberg D Arsland JP Larsen (2000) ArticleTitleHealth related quality of life in Parkinson’s disease: A prospective longitudinal study J Neurol Neurosurg Psychiatry 69 584–589 Occurrence Handle10.1136/jnnp.69.5.584 Occurrence Handle1:STN:280:DC%2BD3M%2FivV2gtg%3D%3D Occurrence Handle11032608
A Schrag M Jahansahi NP Quinn (2000) ArticleTitleWhat contributes to quality of life in patients with Parkinson’s disease? J Neurol Neurosurg Psychiatry 69 308–312 Occurrence Handle10.1136/jnnp.69.3.308 Occurrence Handle1:STN:280:DC%2BD3cvivFChtw%3D%3D Occurrence Handle10945804
AM Kuopio RJ Marttila H Helenius M Toivonen UK Rinne (2000) ArticleTitleThe quality of life in Parkinson’s disease Mov Disord 15 216–223 Occurrence Handle10.1002/1531-8257(200003)15:2<216::AID-MDS1003>3.0.CO;2-# Occurrence Handle1:STN:280:DC%2BD3c3hsVagtg%3D%3D Occurrence Handle10752569
InstitutionalAuthorNameThe Global Parkinson’s Disease Survey (GPDS) Steering Committee (2002) ArticleTitleFactors impacting on quality of life in Parkinson’s disease: Results from an international survey Mov Disord 17 60–67 Occurrence Handle10.1002/mds.10010
JP Larsen K Karlsen E Tandberg (2000) ArticleTitleClinical problems in non-fluctuating patients with Parkinson’s disease: A community based study Mov Disord 15 826–829 Occurrence Handle10.1002/1531-8257(200009)15:5<826::AID-MDS1010>3.0.CO;2-E Occurrence Handle1:STN:280:DC%2BD3cvlt1yjtw%3D%3D Occurrence Handle11009186
Taus C, Giuliani G, Pucci E, D’Amico R, Solari A. Amantadine for fatigue in multiple sclerosis. Cochrane Database Syst Rev 2003; (2): CD002818.
Rosenberg JH, Shafor R. Fatigue in multiple sclerosis: A rational approach to evaluation and treatment. Curr Neurol Neurosci Rep 2005; 5: 140–146.
Zifko UA. Management of fatigue in patients with multiple sclerosis. Drugs 2004; 64: 1295–1304.
N Warren DJ Burn (2004) ArticleTitleThe use of amantadine in Parkinson’s disease and other akinetic-rigid disorders ACNR 4 IssueID5 38–41
Goetz CG. Parkinson’s disease. In: Gilman S (ed), MedLink Neurology. San Diego: MedLink Corporation. Available at http://www.medlink.com. Accessed October 12, 2005.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Martinez-Martin, P., Catalan, M.J., Benito-Leon, J. et al. Impact of Fatigue in Parkinson’s Disease: The Fatigue Impact Scale for Daily Use (D-FIS). Qual Life Res 15, 597–606 (2006). https://doi.org/10.1007/s11136-005-4181-0
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11136-005-4181-0